Agilon Health (NYSE:AGL) Shares Gap Up – What’s Next?

Agilon Health, Inc. (NYSE:AGL)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $92.38, but opened at $96.25. Agilon Health shares last traded at $94.5610, with a volume of 15,126 shares.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. Barclays set a $111.00 price target on shares of Agilon Health and gave the stock an “equal weight” rating in a report on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of Agilon Health in a research note on Monday, August 24th. Wells Fargo & Company restated an “overweight” rating and set a $146.00 price objective (up from $141.00) on shares of Agilon Health in a research report on Tuesday, August 11th. Citigroup upgraded Agilon Health from a “sell” rating to a “neutral” rating and upped their target price for the stock from $105.00 to $115.00 in a research note on Monday, August 10th. Finally, JPMorgan Chase & Co. raised their target price on Agilon Health from $31.00 to $85.00 and gave the company an “underweight” rating in a report on Monday, August 24th. Six research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $102.25.

Agilon Health Stock Up 2.9%

The company has a market capitalization of $1.60 billion, a P/E ratio of -6.55 and a beta of 3.02. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.08 and a current ratio of 1.08. The firm’s fifty day moving average is $99.47 and its 200-day moving average is $70.07.

Agilon Health (NYSE:AGL) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.45 billion. As a group, equities research analysts predict that Agilon Health, Inc. will post -2.9 EPS for the current year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Alpine Global Management LLC bought a new stake in Agilon Health during the 4th quarter worth $84,000. Allworth Financial LP bought a new position in Agilon Health in the second quarter valued at about $114,000. Simplify Asset Management Inc. raised its position in Agilon Health by 92.0% in the fourth quarter. Simplify Asset Management Inc. now owns 218,810 shares of the company’s stock valued at $151,000 after purchasing an additional 104,834 shares during the last quarter. Proficio Capital Partners LLC acquired a new stake in shares of Agilon Health during the second quarter valued at about $210,000. Finally, State of Wyoming boosted its stake in shares of Agilon Health by 64.9% during the fourth quarter. State of Wyoming now owns 359,664 shares of the company’s stock valued at $248,000 after purchasing an additional 141,572 shares in the last quarter.

About Agilon Health

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company focuses primarily on patients enrolled in Medicare Advantage plans and works with physician groups to coordinate care, improve outcomes and manage healthcare costs.

Agilon provides physicians with technology, analytics, operational support and clinical resources designed to help them manage the health of defined patient populations.